Brief: Crinetics Pharmaceuticals Q1 Net Income USD -127.845 Million
May 07 (Reuters) - Crinetics Pharmaceuticals Q1 operating expenses USD 151.112 million. Q1 basic EPS USD -1.23 Q1 operating income USD -140.378 million
Recent news on Crinetics Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
Crinetics will get more time after FDA setback for Camurus' rival drug, Piper Sandler says
Crinetics Pharmaceuticals Q1 revenue jumps on Palsonify launch
Brief: Crinetics Pharmaceuticals Q1 Net Income USD -127.845 Million